Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
SBFM holding history
Sunshine Biopharma Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SBFM overviewAll 13F holders of SBFMFull Q2 2026 holdings
- Shares (Q2 2026)
- 385
- Value
- $808
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 385 | $808 | <0.1% | −14,249−97.4% | Reduced | Holders |
| Q1 2026 | 14,634 | $15.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 14,634 | $18.0K | <0.1% | +10,800+281.7% | Added | Holders |
| Q3 2025 | 3,834 | $5.71K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 3,834 | $5.52K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 3,834 | $7.32K | <0.1% | −3,806−49.8% | Reduced | Holders |
| Q4 2024 | 7,640 | $22.9K | <0.1% | +7,639+763,900.0% | Added | Holders |
| Q3 2024 | 1 | $3 | <0.1% | −999−99.9% | Reduced | Holders |
| Q2 2024 | 1,000 | $418 | <0.1% | +1,000 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −26−100.0% | Sold out | Holders |
| Q3 2023 | 26 | $8 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 26 | $13 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 26 | $19 | <0.1% | +26 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −6,867−100.0% | Sold out | Holders |
| Q2 2022 | 6,867 | $7.00K | <0.1% | +6,867 | New | Holders |